What are the typical consequences of diabetic autonomic neuropathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diabetic Autonomic Neuropathy: Consequences

The correct answers are a (gastroparesis), d (orthostatic hypotension), and e (sweating disorders), as these are all well-established manifestations of diabetic autonomic neuropathy, while hypertension is not a consequence and Charcot arthropathy results from peripheral sensory neuropathy, not autonomic dysfunction. 1

Confirmed Consequences of Diabetic Autonomic Neuropathy

Gastroparesis (Option A - CORRECT)

  • Gastroparesis is a major gastrointestinal manifestation of diabetic autonomic neuropathy, presenting with erratic glycemic control and upper gastrointestinal symptoms. 1
  • The American Diabetes Association explicitly lists gastroparesis among the major clinical manifestations of diabetic autonomic neuropathy, along with other GI disturbances including esophageal dysmotility, constipation, diarrhea, and fecal incontinence. 1
  • Diagnosis requires exclusion of organic causes (peptic ulcer disease, gastric outlet obstruction) via esophagogastroduodenoscopy before specialized testing with gastric emptying scintigraphy. 1

Orthostatic Hypotension (Option D - CORRECT)

  • Orthostatic hypotension is a cardinal feature of cardiac autonomic neuropathy (CAN), defined as a fall in systolic blood pressure >20 mmHg or diastolic blood pressure >10 mmHg upon standing without appropriate compensatory heart rate increase. 1
  • The American Heart Association recognizes orthostatic hypotension as a significant symptom of autonomic neuropathy that can lead to syncope, near-syncope episodes, and exercise intolerance. 2
  • Advanced cardiac autonomic neuropathy presents with orthostatic hypotension and resting tachycardia (>100 bpm), and is independently associated with increased mortality. 1

Sweating Disorders (Option E - CORRECT)

  • Sudomotor dysfunction with either increased or decreased sweating is explicitly listed as a major clinical manifestation of diabetic autonomic neuropathy by the American Diabetes Association. 1
  • Sudomotor dysfunction presents as dry cracked skin, loss of sweating, and changes in sweat function patterns, which can be among the earliest manifestations of autonomic neuropathy. 2, 3
  • These changes contribute to loss of skin integrity, development of fissures and cracks that allow microorganism entry, ultimately leading to ulcers and gangrene. 3

Incorrect Options

Hypertension (Option B - INCORRECT)

  • Hypertension is NOT a consequence of diabetic autonomic neuropathy; in fact, the opposite occurs—autonomic neuropathy causes orthostatic hypotension, not hypertension. 1
  • While blood pressure control is important in diabetes management to slow retinopathy progression, hypertension itself is not caused by autonomic nerve damage. 1

Charcot Arthropathy (Option C - INCORRECT)

  • Charcot arthropathy results from diabetic peripheral neuropathy (sensory and motor nerve damage), not autonomic neuropathy. 1
  • This condition develops from loss of protective sensation in the feet, leading to unrecognized trauma and progressive joint destruction—a consequence of sensory nerve dysfunction, not autonomic dysfunction. 1
  • Up to 50% of diabetic peripheral neuropathy may be asymptomatic, putting patients at risk for injuries to insensate feet if preventive foot care is not implemented. 1

Additional Key Autonomic Manifestations

Cardiovascular System

  • Resting tachycardia, exercise intolerance, silent myocardial ischemia, and hypoglycemia unawareness are all cardiovascular consequences of autonomic neuropathy. 1, 2, 3
  • CAN is associated with mortality independently of other cardiovascular risk factors and doubles the relative risk of silent myocardial ischemia. 1, 3

Genitourinary System

  • Erectile dysfunction, retrograde ejaculation in men, and female sexual dysfunction (decreased desire, pain during intercourse, inadequate lubrication) are genitourinary manifestations. 1, 2
  • Bladder dysfunction presents as urinary incontinence, nocturia, frequent urination, urgency, and weak urinary stream. 1, 2

Critical Clinical Pitfall

  • Up to 50% of autonomic neuropathy cases may be completely asymptomatic, making annual screening essential even without patient complaints, particularly in type 1 diabetes ≥5 years duration and all type 2 diabetes patients. 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diabetic Neuropathy Symptoms and Presentation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetic autonomic neuropathy.

Diabetes care, 2003

Guideline

Diabetic Neuropathy and Creatine Kinase Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What does screening for Diabetic Autonomic Neuropathy (DAN) involve?
What are the treatments for diabetic autonomic neuropathy?
What is the appropriate assessment and management plan for a 30‑ to 40‑year‑old woman with uncontrolled type 2 diabetes mellitus presenting with recurrent hyperglycemia, hypoglycemia‑related loss of consciousness, autonomic and peripheral neuropathy, orthostatic hypotension, possible lower‑respiratory infection, and currently on premixed insulin 70/30, sitagliptin, and atorvastatin?
What is the initial treatment for diabetic autonomic neuropathy?
What is the treatment for diabetic autonomic neuropathy?
My testicles are small; could this be normal or indicate hypogonadism or another endocrine disorder, and what evaluation should I undergo?
What is the next step in managing a patient with manic agitation who is already receiving olanzapine 25 mg daily, aripiprazole 20 mg daily, and lorazepam 6 mg daily?
What is the most appropriate initial approach to a patient presenting with simultaneous shoulder and low-back pain?
After a recent miscarriage, I'm experiencing increased vaginal spotting after physical activity—should I be concerned and what should I do?
Is it appropriate to give haloperidol 1 mg for acute agitation in a patient already receiving olanzapine 25 mg, aripiprazole 20 mg, and lorazepam 6 mg daily?
What are the likely causes of sinus bradycardia in a 67‑year‑old man with advanced head‑and‑neck cancer, chronic smoker, gastrostomy feeding tube receiving enteral nutrition, cirrhosis and on xifaximin, who is not taking any atrioventricular‑nodal blocking medications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.